Flavonols enhanced production of anti-inflammatory substance(s) by bifidobacterium adolescentis: Prebiotic actions of galangin, quercetin, and fisetin

BioFactors

Volumn 39, Issue 4, 2013, Pages 422-429

  Kawabata, Kyuichi ^a   Sugiyama, Yuta ^a   Sakano, Taiken ^a   Ohigashi, Hajime ^a  

^a FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Anti inflammatory activity; Flavonol; Functional interaction; Probiotics

Indexed keywords

2 (3 HYDROXYPHENYL)ACETIC ACID; 3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; 3 AMINO 3 PHENYLPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; ACETIC ACID DERIVATIVE; FISETIN; FLAVONOL DERIVATIVE; GALANGIN; KAEMPFEROL; LIPOPOLYSACCHARIDE; MYRICETIN; NITRIC OXIDE; PHLOROGLUCINOL; PREBIOTIC AGENT; PROBIOTIC AGENT; QUERCETIN; RESORCINOL; UNCLASSIFIED DRUG; CULTURE MEDIUM; FLAVONOID; HYDROXYBENZOIC ACID DERIVATIVE;

ANAEROBIC METABOLISM; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM ADOLESCENTIS; CELL COUNT; CELL LINE; COCULTURE; CONTROLLED STUDY; DRUG POTENTIATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; TIME; ANIMAL; BACTEROIDES; BIFIDOBACTERIUM; CULTURE MEDIUM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LACTOBACILLUS; MEGASPHAERA; METABOLISM;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS;

ANIMALS; BACTEROIDES; BIFIDOBACTERIUM; CELL LINE; CULTURE MEDIA, CONDITIONED; FLAVONOIDS; HYDROXYBENZOATES; LACTOBACILLUS; LIPOPOLYSACCHARIDES; MEGASPHAERA; MICE; NITRIC OXIDE; PREBIOTICS; PROBIOTICS; QUERCETIN;

EID: 84881641465     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1081     Document Type: Article

References (34)

1. Mitsuoka, T. (1990) Bifidobacteria and their role in human health. J. Ind. Microbiol. 6, 263-267.
2. Mitsuoka, T., and Kaneuchi, C. (1977) Ecology of the bifidobacteria. Am. J. Clin. Nutr. 30, 1799-1810.
3. Yang, C. S., Sang, S., Lambert, J. D., and Lee, M. (2008) Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol. Nutr. Food. Res. 52, (Suppl. 1), S139-S151.
4. Gibson, G. R., and Roberfroid, M. B. (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401-1412.
5. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., Taylor, T. D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M., and Ohno, H. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 469, 543-547.
6. Pokusaeva, K., Fitzgerald, G. F., and van Sinderen, D. (2011) Carbohydrate metabolism in Bifidobacteria. Genes. Nutr. 6, 285-306.
7. Maslowski, K. M. and Mackay, C. R. (2011) Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5-9.
8. Belenguer, A., Duncan, S. H., Calder, A. G., Holtrop, G., Louis, P., Lobley, G. E., and Flint, H. J. (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72, 3593-3599.
9. Bokkenheuser, V. D., Shackleton, C. H., and Winter, J. (1987) Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem. J. 248, 953-956.
10. Aura, A. M., O'Leary, K. A., Williamson, G., Ojala, M., Bailey, M., Puupponen-Pimia, R., Nuutila, A. M., Oksman-Caldentey, K. M., and Poutanen, K. (2002) Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food. Chem. 50, 1725-1730.
11. Decroos, K., Vanhemmens, S., Cattoir, S., Boon, N., and Verstraete, W. (2005) Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch. Microbiol. 183, 45-55.
12. Ueno, T., Uchiyama, S., and Kikuchi, N. (2002) The role of intestinal bacteria on biological effects of soy isoflavones in humans. J. Nutr. 132, 594S.
13. Arai, Y., Uehara, M., Sato, Y., Kimira, M., Eboshida, A., Adlercreutz, H., and Watanabe, S. (2000) Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 10, 127-135.
14. Winter, J., Moore, L. H., Dowell, V. J., and Bokkenheuser, V. D. (1989) C-ring cleavage of flavonoids by human intestinal bacteria. Appl. Environ. Microbiol. 55, 1203-1208.
15. Schneider, H., and Blaut, M. (2000) Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch. Microbiol. 173, 71-75.
16. Tzounis, X., Vulevic, J., Kuhnle, G. C., George, T., Leonczak, J., Gibson, G. R., Kwik-Uribe, C., and Spencer, J. E. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 99, 782-792.
17. Selma, M. V., Espin, J. C., and Tomas-Barberan, F. A. (2009) Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food. Chem. 57, 6485-6501.
18. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138.
19. Kawabata, K., Sawada, K., Ikeda, K., Fukuda, I., Kawasaki, K., Yamamoto, N., and Ashida, H. (2011) Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. Mol. Nutr. Food. Res. 55, 467-475.
20. Kinouchi, T., Kataoka, K., Bing, S. R., Nakayama, H., Uejima, M., Shimono, K., Kuwahara, T., Akimoto, S., Hiraoka, I., and Ohnishi, Y. (1998) Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation. Microbiol. Immunol. 42, 347-355.
21. Khokhlova, E. V., Smeianov, V. V., Efimov, B. A., Kafarskaia, L. I., Pavlova, S. I., and Shkoporov, A. N. (2012) Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol. Immunol. 56, 27-39.
22. Kim, D. H., Jung, E. A., Sohng, I. S., Han, J. A., Kim, T. H., and Han, M. J. (1998) Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21, 17-23.
23. Raimondi, S., Roncaglia, L., De Lucia, M., Amaretti, A., Leonardi, A., Pagnoni, U. M., and Rossi, M. (2009) Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl. Microbiol. Biotechnol. 81, 943-950.
24. Tsangalis, D., Ashton, J. F., McGill, A. J., and Shah, N. P. (2002) Enzymic Transformation of isoflavone phytoestrogens in soymilk by β-glucosidase-producing bifidobacteria. J. Food. Sci. 67, 3104-3113.
25. Marotti, I., Bonetti, A., Biavati, B., Catizone, P., and Dinelli, G. (2007) Biotransformation of common bean (Phaseolus vulgaris L.) flavonoid glycosides by Bifidobacterium species from human intestinal origin. J. Agric. Food. Chem. 55, 3913-3919.
26. Roncaglia, L., Amaretti, A., Raimondi, S., Leonardi, A., and Rossi, M. (2011) Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside. Appl. Microbiol. Biotechnol. 92, 159-168.
27. Monagas, M., Khan, N., Andres-Lacueva, C., Urpi-Sarda, M., Vazquez-Agell, M., Lamuela-Raventos, R. M., and Estruch, R. (2009) Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br. J. Nutr. 102, 201-206.
28. Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Raimondi, S., Matteuzzi, D., and Rossi, M. (2007) Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J. Nutr. 137, 2742-2746.
29. Frick, J. S., Fink, K., Kahl, F., Niemiec, M. J., Quitadamo, M., Schenk, K., and Autenrieth, I. B. (2007) Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect. Immun. 75, 3490-3497.
30. Chen, J., Wang, R., Li, X., and Wang, R. (2012) Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br. J. Nutr. 107, 1429-1434.
31. Huang, H., and Chang, T. (2012) Antioxidative properties and inhibitory effect of Bifidobacterium adolescentis on melanogenesis. World. J. Microbiol. Biotechnol. 28, 2903-2912.
32. Menard, S., Candalh, C., Bambou, J. C., Terpend, K., Cerf-Bensussan, N., and Heyman, M. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut. 53, 821-828.
33. Imaoka, A., Shima, T., Kato, K., Mizuno, S., Uehara, T., Matsumoto, S., Setoyama, H., Hara, T., and Umesaki, Y. (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World. J. Gastroenterol. 14, 2511-2516.
34. Heuvelin, E., Lebreton, C., Grangette, C., Pot, B., Cerf-Bensussan, N., and Heyman, M. (2009) Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS. One. 4, e5184.